Does Dr. ALIREZA ABDOLMOHAMMADI have financial conflicts of interest?

Dr. ALIREZA ABDOLMOHAMMADI (MD) has received a total of $412 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $412 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALIREZA ABDOLMOHAMMADI?

According to CMS Open Payments data, Dr. ALIREZA ABDOLMOHAMMADI received funding from PFIZER ($189), INCYTE CORPORATION ($119), and SIEMENS MEDICAL SOLUTIONS USA ($67).

Does Dr. ALIREZA ABDOLMOHAMMADI receive research grants or speaking fees?

Dr. ALIREZA ABDOLMOHAMMADI has received $412 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ALIREZA ABDOLMOHAMMADI

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: TACOMA, WA 98405

NPI Number: 1871816207

LIFETIME INDUSTRY VALUE

$412

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDOLMOHAMMADI is a verified Internal Medicine, Medical Oncology practitioner based in TACOMA, WA.

Between 2021 and 2024, Dr. ABDOLMOHAMMADI had an overall industry promotional and research financial footprint of $412 as recorded in the federal CMS Open Payments database.

$412 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDOLMOHAMMADI's primary funding source is PFIZER, which accounts for $189 (representing 45.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PFIZER

Rank 1

$189

45.9%

INCYTE CORPORATION

Rank 2

$119

28.8%

SIEMENS MEDICAL SOLUTIONS USA

Rank 3

$67

16.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.